Beta Bionics (BBNX) Equity Ratio (2023 - 2026)

Beta Bionics has disclosed Equity Ratio across 4 years of filings, most recently posting 0.89 for Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.89, down 4.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.89 (down 4.0% YoY), and the FY2025 annual result was 0.87, up 153.36% from the prior year.
• Equity Ratio came in at 0.89 for Q1 2026 at Beta Bionics, up from 0.87 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.93 in Q1 2025 to a low of 1.85 in Q4 2023.
• The 4-year median for Equity Ratio is 0.89 (2026), against an average of 0.15.
• Across the five-year window, Equity Ratio jumped 153.36% in 2025 and retreated 4.0% in 2026, its largest moves.
• Beta Bionics' Equity Ratio stood at 1.85 in 2023, then climbed by 11.17% to 1.64 in 2024, then surged by 153.36% to 0.87 in 2025, then gained by 1.85% to 0.89 in 2026.
• The last three Equity Ratio figures came in at 0.89 (Q1 2026), 0.87 (Q4 2025), and 0.89 (Q3 2025), per Business Quant data.